Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cloud Pharmaceuticals Inc.
DescriptionHistone deacetylase 8 (HDAC8) inhibitor
Molecular Target Histone deacetylase 8 (HDAC8)
Mechanism of ActionHistone deacetylase 8 (HDAC8) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationT cell lymphoma
Indication DetailsTreat T cell lymphoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today